Evaluating 3778 patch test results, we studied prevalence and localiza
tion of benzocaine contact sensitization as well as the duration of hi
story. We were particularly interested in the role of other ''para-gro
up'' allergens and in patients with stasis dermatitis of the legs. Alt
hough the sensitizing effect of benzocaine is well known and the subst
ance has been increasingly substituted by other modern anesthetics, it
is still widely used in Germany and produced positive reactions in 65
% of our cases. Therefore, it should remain part of the patch test st
andard series. Of our positives to benzocaine 59.2 % were associated w
ith positive patch tests to substances of the para-group. The high ave
rage age and the cumulative incidence of benzocaine contact allergies
after long-lasting treatment of chronic diseases show the low sensitiz
ing potential of benzocaine. Nevertheless long-lasting topical treatme
nt with benzocaine, often combined with polypragmasia, leads to a high
number of sensitizations. As stasis dermatitis of the legs meets the
ideal requirements of sensitization, it is important to restrict the t
opical application of potential allergens such as benzocaine or other
substances of the para-group.